IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance
(NASDAQ: ICCM) Delayed: 5.93 +0.53 (9.81%)
Previous Close $5.40    52 Week High $ 
Open $7.06    52 Week Low $ 
Day High $7.53    P/E N/A 
Day Low $5.61    EPS $ 
Volume 15,845,462